Drugs / XinNaoJing
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06927336 | Apr 2025 → Jun 2026 overdue | brain injury | The Second Affiliated Hospital of Kunming Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XinNaoJing | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06927336 ↗ |
| Known as | Xingnaojing | “The dosage of XingNaoJing was 20 ml each time by intravenous drip” NCT06927336 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Xingnaojing injection is a kind of traditional Chinese medicine preparation” NCT06927336 ↗ |
| Route | Intravenous | “by intravenous drip” NCT06927336 ↗ |